Sažetak
Uvod/Cilj. Prekomerna telesna masa i gojaznost postali su značajan zdravstveni problem u razvijenim zemljama, a mogu biti povezani sa prisustvom hronične inflamacije niskog intenziteta u belom masnom tkivu. Cilj rada bio je da se ispitaju nivoi markera inflamacije, C-reaktivnog proteina (CRP), i njegova povezanost sa standardnim antropometrijskim parametrima kod predgojaznih i gojaznih žena. Metode. Studijom je bilo obuhvaćeno 200 zdravih žena (18–45 god) kojima su određeni standardni i alternativni antropometrijski parametari [indeks telesne mase (BMI), procenat masti (%F), obim struka (WC), odnos obima struka i kukova (WHR), odnos obima struka i visine (WHtR), kao i indeks telesne masnoće (BAI)] koji su zatim korelisani sa koncentracijama CRP u serumu. Rezultati. Prosečna vrednost nivoa CRP u serumu u celoj grupi iznosila je 5,56 ± 2,43 mg/L i utvrđena je njegova značajna pozitivna korelacija sa svim ispitivanim antropometrijskim parametrima. Uočena je statistički značajna razlika između grupa predgojaznih i gojaznih žena u svim ispitivanim antropometrijskim parametrima, kao i u pogledu koncentracije CRP. U grupi gojaznih ispitanica utvrđena je značajna povezanost između CRP i svih antropometrijskih parametara, dok u predgojaznoj grupi nije zabeležena statistička značajnost. U grupi gojaznih, svi antropometrijski pokazatelji pokazali su značajnu korelaciju sa procentom telesne masti, a kod predgojaznih žena, korelacija je bila značajna samo za telesnu masu, BMI, WC i WHtR. Zaključak. Između predgojaznih i gojaznih ispitanica postoji značajna razlika u pogledu svih pokazatelja centralne gojaznosti, kao i u pogledu koncentacije CRP u serumu. U grupi gojaznih, pokazana je značajna korelacija između sadržaja masti, izraženog kao procenat masnoće, i svih pokazatelja visceralne distribucije masti, dok u grupi predgojaznih značajna povezanost nije urađena za WHR и BAI. Naši rezultati potvrđuju da CRP može predstavljati značajan marker metaboličkog rizika kod gojaznih žena, kao i da je BMI, iako spada u tradicionalne parametre, i dalje pouzdan pokazatelj sadržaja telesne masti.
Ključne reči
Array
Array
Array
Array
Reference
REFERENCES
Stepien M, Stepien A, Wlazel RN, Paradowski M, Banach M, Rysz J. Obesity indices and inflammatory markers in obese non-diabetic normo- and hypertensive patients: A comparative pi-lot study. Lipids Health Dis 2014; 13: 29−38.
Stepien M, Stepien A, Wlazel RN, Paradowski M, Rizzo M, Banach M, et al. Predictors of insulin resistance in patients with obe-sity: A pilot study. Angiology 2014; 65(1): 22−30.
Pannacciulli N, Cantatore FP, Minenna A, Bellacicco M, Giorgino R, de Pergola G. C-reactive protein is independently associated with total body fat, central fat, and insulin resistance in adult women. Int J Obes Relat Metab Disord 2001; 25(10): 1416−20.
Jialal I, Devaraj S, Venugopal SK. C-reactive protein: Risk marker or mediator in atherothrombosis?. Hypertension 2004; 44(1): 6−11.
Koenig W, Sund M, Fröhlich M, Fischer HG, Löwel H, Döring A, et al. C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: Results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augs-burg Cohort Study. Circulation 1999; 99(2): 237−42.
Ridker PM. Clinical application of C-reactive protein for car-diovascular disease detection and prevention. Circulation 2003; 107(3): 363−9.
Zeba AN, Delisle HF, Rosier C, Renier G. Association of high-sensitive C-reactive protein with cardiomatabolic risk factors and micronutrient deficiencies in adults of Ougadougou, Burk-ina Faso. Br J Nutr 2013; 109(7): 1266−75.
Sims EA. Are there persons who are obese, but metabolically healthy?. Metabolism 2001; 50(12): 1499−504.
World Healtj Organization. Obesity: Preventing and managing the global epidemic. Geneva: World Health Organization; 2000.
Durnin JV, Womersley J. Body fat assessed from total body den-sity and its estimation from skinfold thickness: measurements on 481 men and women aged from 16 to 72 years. Br J Nutr 1974; 32(1): 77−97.
Bergman RN, Stefanovski D, Buchanan TA, Sumner AE, Reynolds JC, Sebring NG, et al. A better index of body adiposity. Obesity 2011; 19(5): 1083−9.
Lee CM, Huxley RR, Wildman RP, Woodward M. Indices of ab-dominal obesity are better discriminators of cardiovascular risk factors than BMI: a meta-analysis. J Clin Epidemiol 2008; 61(7): 646−53.
Karastergiou K, Smith SR, Greenberg AS, Fried SK. Sex differences in human adipose tissues - the biology of pear shape. Biol Sex Differ 2012; 3(1): 13.
Stojanovic D, Visnjic A, Mitrovic V, Stojanovic M. Risk factors for the occurrence of cardiovascular system diseases in students. Vojnosanit Pregl 2009; 66(6): 453−8. (Serbian)
Balistreri CR, Caruso C, Candore G. The role of adipose tissue and adipokines in obesity-related inflammatory diseases. Me-diators Inflamm 2010; 2010: 802078.
Rexrode KM, Pradahan A, Manson JE, Buring JE, Ridker PM. Re-lationship of total and abdominal adiposity with CRP and IL-6 in women. Ann Epidemiol 2003; 13: 674−82.
Leal Vde O, Mafra D. Adipokines in obesity. Clin Chim Acta 2013; 419: 87−94.
Coelho M, Oliveira T, Fernandes R. Biochemistry of adipose tis-sue: an endocrine organ. Arch Med Sci 2013; 9(2): 191−200.
Ouchi N, Parker JL, Lugus JJ, Walsh K. Adipokines in inflamma-tion and metabolic disease. Nat Rev Immunol 2011; 11(2): 85−97.
Fuentes E, Fuentes F, Vilahur G, Badimon L, Palomo I. Mecha-nisms of chronic state of inflammation as mediators that link obese adipose tissue and metabolic syndrome. Mediators In-flamm 2013; 2013: 136584.
Rodriguez-Hernandez H, Simental-Mendia LE, Rodriguez-Ramirez G, Reyes-Romero MA. Obesity and imflammation: Epidemiology, risk factors, and markers of inflammation. Int J Endocrinol 2013; 2013: 678159.
Patel PS, Buras ED, Balasubramanyam A. The role of immune system in obesity and insulin resistance. J Obes 2013; 2013: 616193.
Han JM, Levings MK. Immune regulation in obesity-associated adipose inflammation. J Immunol 2013; 191(2): 527−32.
Bluher M. Adipose tissue dysfunction contributes to obesity re-lated metabolic diseases. Best Prac Res Clin Endocrinol Metab 2013; 27(2): 163−77.
Berg AH, Scherer PE. Adipose tissue, inflammation, and cardio-vascular disease. Circ Res 2005; 96(9): 939−49.
Visser M, Bouter LM, McQuillan GM, Were MH, Harris TB. Low-grade systemic inflammation in overweight children. Pediatrics 2001; 107(1): E13.
Forsythe LK, Livingstone MB, Barnes MS, Horigan G, Wallace JM. C-reactive protein and body composition in a representative sample of young adults. Proceed Nutr Soc 2009; 67(OCE7): E267.